GH Guardant Health Inc

$105.42

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Guardant Health's upcoming earnings report on October 29 is poised to capture attention, particularly as the company continues to navigate the competitive landscape of precision oncology. With an EPS estimate of $0.00, the market is keenly observing whether Guardant can meet or exceed this benchmark, especially given the whisper number aligning at the same level. The revenue estimate stands at $235.64 million, a figure that reflects the company's ongoing efforts to expand its market reach and enhance its product offerings. Despite the lack of recent news, Guardant's substantial market cap of over $8.1 billion underscores investor confidence in its long-term growth potential. As the company remains at the forefront of innovative cancer diagnostics, stakeholders will be watching closely for any strategic insights or forward-looking statements that could influence market sentiment and drive future performance.

Updated On 11/21/2025

About Guardant Health Inc

Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.

Website: https://guardanthealth.com

Sector
LIFE SCIENCES
Industry
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1576280
Address
505 PENOBSCOT DR., REDWOOD CITY, CA, US
Valuation
Market Cap
$5.55B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
55.67
Performance
EPS
$-3.56
Dividend Yield
—
Profit Margin
-59.10%
ROE
-4584.00%
Technicals
50D MA
$43.59
200D MA
$33.66
52W High
$50.89
52W Low
$16.77
Fundamentals
Shares Outstanding
123M
Target Price
$56.71
Beta
1.45

GH EPS Estimates vs Actual

● Estimated
● Actual

GH News & Sentiment

Nov 20, 2025 • Benzinga BULLISH
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday - Cipher Mining ( NASDAQ:CIFR ) , Aduro Clean Technologies ( NASDAQ:ADUR )
U.S. stocks were higher, with the Dow Jones gaining more than 250 points on Thursday. Shares of Nutex Health Inc ( NASDAQ:NUTX ) rose sharply during Thursday's session after the company reported better-than-expected third-quarter financial results.
Nov 18, 2025 • Benzinga SOMEWHAT-BULLISH
6 Healthcare Stocks With Strong Upward Momentum - Cardinal Health ( NYSE:CAH ) , Abivax ( NASDAQ:ABVX )
Out with the old ( tech ) , in with the new ( healthcare ) . After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.
Nov 14, 2025 • Zacks Commentary NEUTRAL
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.
Nov 08, 2025 • Motley Fool SOMEWHAT-BULLISH
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
These companies are slowly coming into their own.
Nov 06, 2025 • Benzinga SOMEWHAT-BULLISH
Cathie Wood Makes $13.4 Million Bet On This Social Network After Earnings Crash - But Dumps Robinhood And Reddit - Pinterest ( NYSE:PINS )
Cathie Wood-led Ark Invest made significant trades on Wednesday, focusing on Pinterest Inc. ( NYSE:PINS ) , Robinhood Markets Inc. ( NASDAQ:HOOD ) , and Reddit Inc. ( NYSE:RDDT ) . These trades come amid notable earnings reports and market reactions.
Nov 04, 2025 • Benzinga SOMEWHAT-BULLISH
Cathie Wood Dumps $7.9 Million Worth Of Palantir Stock Despite 121% Revenue Surge - Ark Doubles Down On Peter Thiel's Buzzy Crypto Upstart - Palantir Technologies ( NASDAQ:PLTR )
On Monday, Cathie Wood-led Ark Invest made notable trades, including a significant purchase of Bullish ( NYSE:BLSH ) shares and a sell-off of Palantir Technologies Inc ( NASDAQ:PLTR ) stock.
Sentiment Snapshot

Average Sentiment Score:

0.161
50 articles with scored sentiment

Overall Sentiment:

Bullish

GH Reported Earnings

Jul 30, 2025
Jun 30, 2025 (Pre market)
0.28 Surprise
  • Reported EPS: $-0.44
  • Estimate: $-0.72
  • Whisper: —
  • Surprise %: 38.9%
Apr 30, 2025
Mar 31, 2025 (Post market)
0.36 Surprise
  • Reported EPS: $-0.49
  • Estimate: $-0.85
  • Whisper: —
  • Surprise %: 42.4%
Feb 20, 2025
Dec 31, 2024 (Post market)
-0.12 Surprise
  • Reported EPS: $-0.62
  • Estimate: $-0.50
  • Whisper: —
  • Surprise %: -23.1%
Nov 06, 2024
Sep 30, 2024 (Post market)
-0.14 Surprise
  • Reported EPS: $-0.88
  • Estimate: $-0.74
  • Whisper: —
  • Surprise %: -18.9%
Aug 07, 2024
Jun 30, 2024 (Post market)
-0.1 Surprise
  • Reported EPS: $-0.84
  • Estimate: $-0.74
  • Whisper: —
  • Surprise %: -13.5%
May 09, 2024
Mar 31, 2024 (Post market)
-0.09 Surprise
  • Reported EPS: $-0.94
  • Estimate: $-0.85
  • Whisper: —
  • Surprise %: -10.6%
Feb 22, 2024
Dec 31, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $-0.85
  • Estimate: $-0.86
  • Whisper: —
  • Surprise %: 1.2%
Nov 06, 2023
Sep 30, 2023 (Post market)
0.22 Surprise
  • Reported EPS: $-0.73
  • Estimate: $-0.95
  • Whisper: —
  • Surprise %: 23.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.51 Surprise
  • Reported EPS: $-0.67
  • Estimate: $-1.18
  • Whisper: —
  • Surprise %: 43.2%

Financials